Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Keck

Showing results (161-170 of 608) with videos related to

Pageof 61
Sort By:
Biological Psychiatry|October 20, 1998
Specific treatment of the neuroleptic malignant syndromeS N Caroff, S C Mann, P E Keck
The Journal of Nervous and Mental Disease|February 1, 1990
Lycanthropy and self-identificationA R Kulick, H G Pope, P E Keck
Forschende Komplementarmedizin (2006)|March 11, 2010
A hypericum extract in the treatment of depressive symptoms in outpatients: an open studyJörg Melzer, Reto Brignoli, Martin E Keck, et al.
The American Journal of Psychiatry|July 11, 1991
Declining frequency of neuroleptic malignant syndrome in a hospital populationP E Keck, H G Pope, S L McElroy
Cellular Signalling|January 1, 1989
Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68F Van Valen, H Jürgens, W Winkelmann, et al.
Journal of Child and Adolescent Psychopharmacology|June 25, 1998
Gabapentin in the treatment of adolescent mania: a case reportC A Soutullo, L S Casuto, P E Keck
The Journal of Clinical Psychiatry|December 31, 1997
Resolution of fluoxetine-induced sexual dysfunction with the 5-HT3 antagonist granisetronE B Nelson, P E Keck, S L McElroy
Journal of Clinical Psychopharmacology|December 1, 1988
Beta-adrenergic antagonists in psychosis: is improvement due to treatment of neuroleptic-induced akathisia?J F Lipinski, P E Keck, S L McElroy
The American Journal of Psychiatry|June 2, 2007
Neuroleptic malignant syndromeJeffrey R Strawn, Paul E Keck, Stanley N Caroff
Journal of Clinical Psychopharmacology|February 1, 1987
Sodium valproate: its use in primary psychiatric disordersS L McElroy, P E Keck, H G Pope
Pageof 61

Showing results (161-170 of 608) with videos related to

Sort By:
Pageof 61
Biological Psychiatry|October 20, 1998
Specific treatment of the neuroleptic malignant syndromeS N Caroff, S C Mann, P E Keck
The Journal of Nervous and Mental Disease|February 1, 1990
Lycanthropy and self-identificationA R Kulick, H G Pope, P E Keck
Forschende Komplementarmedizin (2006)|March 11, 2010
A hypericum extract in the treatment of depressive symptoms in outpatients: an open studyJörg Melzer, Reto Brignoli, Martin E Keck, et al.
The American Journal of Psychiatry|July 11, 1991
Declining frequency of neuroleptic malignant syndrome in a hospital populationP E Keck, H G Pope, S L McElroy
Cellular Signalling|January 1, 1989
Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68F Van Valen, H Jürgens, W Winkelmann, et al.
Journal of Child and Adolescent Psychopharmacology|June 25, 1998
Gabapentin in the treatment of adolescent mania: a case reportC A Soutullo, L S Casuto, P E Keck
The Journal of Clinical Psychiatry|December 31, 1997
Resolution of fluoxetine-induced sexual dysfunction with the 5-HT3 antagonist granisetronE B Nelson, P E Keck, S L McElroy
Journal of Clinical Psychopharmacology|December 1, 1988
Beta-adrenergic antagonists in psychosis: is improvement due to treatment of neuroleptic-induced akathisia?J F Lipinski, P E Keck, S L McElroy
The American Journal of Psychiatry|June 2, 2007
Neuroleptic malignant syndromeJeffrey R Strawn, Paul E Keck, Stanley N Caroff
Journal of Clinical Psychopharmacology|February 1, 1987
Sodium valproate: its use in primary psychiatric disordersS L McElroy, P E Keck, H G Pope
Pageof 61